Alumis (ALMS) Net Income (2023 - 2025)

Alumis' (ALMS) quarterly Net Income came in at -$92.9 million in Q4 2025, down 181.75% year-on-year from $113.6 million in Q4 2024, and up 16.13% on a QoQ basis from -$110.8 million in Q3 2025.

Alumis (ALMS) Net Income (2023 - 2025) Analysis & Trends

Alumis (ALMS) has 3 years of Net Income data on file, last reported at -$92.9 million in Q4 2025.

  • On a quarterly basis, Net Income fell 181.75% year-over-year to -$92.9 million in Q4 2025; TTM through Dec 2025 was -$250.9 million, a 8.38% decrease from a year earlier, with the FY2025 full-year figure at -$243.3 million, down 4.66% from the prior year.
  • Net Income for Q4 2025 stood at -$92.9 million, up from -$110.8 million in the prior quarter.
  • Over the last five years, Net Income for ALMS reached as high as $59.3 million in Q2 2025 and fell as low as -$110.8 million in Q3 2025.
  • Historically, Net Income has averaged -$55.0 million across 3 years, with a median of -$48.9 million in 2024.
  • On a YoY basis, Net Income climbed as much as 204.98% in 2025 and fell as far as 181.75% in 2025.
  • Year by year, Net Income stood at -$41.3 million in 2023, then increased by 20.16% to -$33.0 million in 2024, then sank by 181.75% to -$92.9 million in 2025.
  • Per Business Quant data, the three most recent Net Income figures were -$92.9 million in Q4 2025, -$110.8 million in Q3 2025, and $59.3 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -37.09 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 227.36 Mn
4 NuCana 279.75 Bn 279.75 Bn - -3.31 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.03 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 727.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -26.94 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 362.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -453.82 Mn
10 Alumis 2.41 Bn 2.10 Bn - -92.89 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -92.89 Mn
Sep 30, 2025 -110.75 Mn
Jun 30, 2025 59.32 Mn
Mar 31, 2025 -106.62 Mn
Dec 31, 2024 -32.97 Mn
Sep 30, 2024 -93.12 Mn
Jun 30, 2024 -56.51 Mn
Mar 31, 2024 -48.94 Mn
Dec 31, 2023 -41.30 Mn
Sep 30, 2023 -44.56 Mn
Jun 30, 2023 -36.71 Mn